News items related to: Call to action
-
The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Activists gathered at the Brazilian Patent Office (INPI) in Rio de Janeiro this week, and Gilead’s office in São Paulo....
-
When will ViiV, Clinton Health and partners officially repair the mistake on missing out 39 countries from the DTG pricing agreement?
It has been six months since we alerted the Clinton Health Access Initiative (CHAI) to a glaring omission in the...
-
ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
-
“Southern Africa must be innovative to tackle access to HIV and TB treatment” says ARASA
The right to life is being denied due to high prices for medicines. Addressing pharmaceuticals’ abuse of intellectual property law...
-
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
AbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
-
African treatment advocates call on ViiV Healthcare to unlock access to dolutegravir for North Africa now
On 1 December 2015 in Harare , at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates...
